129 related articles for article (PubMed ID: 24780878)
1. Cathepsin S controls adipocytic and osteoblastic differentiation, bone turnover, and bone microarchitecture.
Rauner M; Föger-Samwald U; Kurz MF; Brünner-Kubath C; Schamall D; Kapfenberger A; Varga P; Kudlacek S; Wutzl A; Höger H; Zysset PK; Shi GP; Hofbauer LC; Sipos W; Pietschmann P
Bone; 2014 Jul; 64():281-7. PubMed ID: 24780878
[TBL] [Abstract][Full Text] [Related]
2. Increased fracture callus mineralization and strength in cathepsin K knockout mice.
Gentile MA; Soung do Y; Horrell C; Samadfam R; Drissi H; Duong LT
Bone; 2014 Sep; 66():72-81. PubMed ID: 24928497
[TBL] [Abstract][Full Text] [Related]
3. Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program.
Rosen CJ; Ackert-Bicknell CL; Adamo ML; Shultz KL; Rubin J; Donahue LR; Horton LG; Delahunty KM; Beamer WG; Sipos J; Clemmons D; Nelson T; Bouxsein ML; Horowitz M
Bone; 2004 Nov; 35(5):1046-58. PubMed ID: 15542029
[TBL] [Abstract][Full Text] [Related]
4. Role of the P2Y13 receptor in the differentiation of bone marrow stromal cells into osteoblasts and adipocytes.
Biver G; Wang N; Gartland A; Orriss I; Arnett TR; Boeynaems JM; Robaye B
Stem Cells; 2013 Dec; 31(12):2747-58. PubMed ID: 23629754
[TBL] [Abstract][Full Text] [Related]
5. Accelerated turnover of metaphyseal trabecular bone in mice overexpressing cathepsin K.
Kiviranta R; Morko J; Uusitalo H; Aro HT; Vuorio E; Rantakokko J
J Bone Miner Res; 2001 Aug; 16(8):1444-52. PubMed ID: 11499867
[TBL] [Abstract][Full Text] [Related]
6. IL-1 plays an important role in the bone metabolism under physiological conditions.
Lee YM; Fujikado N; Manaka H; Yasuda H; Iwakura Y
Int Immunol; 2010 Oct; 22(10):805-16. PubMed ID: 20679512
[TBL] [Abstract][Full Text] [Related]
7. Contrasting roles of leukemia inhibitory factor in murine bone development and remodeling involve region-specific changes in vascularization.
Poulton IJ; McGregor NE; Pompolo S; Walker EC; Sims NA
J Bone Miner Res; 2012 Mar; 27(3):586-95. PubMed ID: 22143976
[TBL] [Abstract][Full Text] [Related]
8. Bone status of adult female butyrylcholinesterase gene-deficient mice.
Haupt M; Kauschke V; Sender J; Kampschulte M; Kovtun A; Dürselen L; Heiss C; Lips KS
Int Immunopharmacol; 2015 Nov; 29(1):208-14. PubMed ID: 26138460
[TBL] [Abstract][Full Text] [Related]
9. Osteoclast polarization is not required for degradation of bone matrix in rachitic FGF23 transgenic mice.
Hollberg K; Marsell R; Norgård M; Larsson T; Jonsson KB; Andersson G
Bone; 2008 Jun; 42(6):1111-21. PubMed ID: 18346951
[TBL] [Abstract][Full Text] [Related]
10. Netoglitazone is a PPAR-gamma ligand with selective effects on bone and fat.
Lazarenko OP; Rzonca SO; Suva LJ; Lecka-Czernik B
Bone; 2006 Jan; 38(1):74-84. PubMed ID: 16137931
[TBL] [Abstract][Full Text] [Related]
11. The immune regulatory protein B7-H3 promotes osteoblast differentiation and bone mineralization.
Suh WK; Wang SX; Jheon AH; Moreno L; Yoshinaga SK; Ganss B; Sodek J; Grynpas MD; Mak TW
Proc Natl Acad Sci U S A; 2004 Aug; 101(35):12969-73. PubMed ID: 15317945
[TBL] [Abstract][Full Text] [Related]
12. Regulation of bone mass and bone turnover by neuronal nitric oxide synthase.
van't Hof RJ; Macphee J; Libouban H; Helfrich MH; Ralston SH
Endocrinology; 2004 Nov; 145(11):5068-74. PubMed ID: 15297441
[TBL] [Abstract][Full Text] [Related]
13. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
[TBL] [Abstract][Full Text] [Related]
14. Targeted overexpression of G protein-coupled receptor kinase-2 in osteoblasts promotes bone loss.
Wang L; Liu S; Quarles LD; Spurney RF
Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E826-34. PubMed ID: 15585587
[TBL] [Abstract][Full Text] [Related]
15. Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cell cultures.
Justesen J; Stenderup K; Eriksen EF; Kassem M
Calcif Tissue Int; 2002 Jul; 71(1):36-44. PubMed ID: 12200657
[TBL] [Abstract][Full Text] [Related]
16. Conditional deletion of Bmpr1a in differentiated osteoclasts increases osteoblastic bone formation, increasing volume of remodeling bone in mice.
Okamoto M; Murai J; Imai Y; Ikegami D; Kamiya N; Kato S; Mishina Y; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2011 Oct; 26(10):2511-22. PubMed ID: 21786321
[TBL] [Abstract][Full Text] [Related]
17. Low-dose PTH increases osteoblast activity via decreased Mef2c/Sost in senescent osteopenic mice.
Saidak Z; Le Henaff C; Azzi S; Marty C; Marie PJ
J Endocrinol; 2014 Oct; 223(1):25-33. PubMed ID: 25056116
[TBL] [Abstract][Full Text] [Related]
18. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin receptor 1 regulates bone formation and osteoblast differentiation by GSK-3β/β-catenin signaling in mice.
Lin YY; Chen CY; Chuang TY; Lin Y; Liu HY; Mersmann HJ; Wu SC; Ding ST
Bone; 2014 Jul; 64():147-54. PubMed ID: 24713193
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of osteoblast differentiation but not adipocyte differentiation of mesenchymal stem cells by sera obtained from aged females.
Abdallah BM; Haack-Sørensen M; Fink T; Kassem M
Bone; 2006 Jul; 39(1):181-8. PubMed ID: 16530029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
